Attovia (ATTO) 10% Owner Frazier Life Sciences Buys $10M Shares

What Happened

• Frazier Life Sciences XI, L.P. (reported as a 10% owner) made an open‑market purchase of 588,235 Attovia (ATTO) shares on 2026-08-06 at $17.00 per share for a total of $9,999,995. On the same day the filer recorded multiple conversions of derivative securities into common stock: acquisitions of 1,749,192; 1,590,175; 1,189,940; and 961,322 shares (total acquired by conversion = 5,490,629). The filing also shows conversion-related dispositions recorded at $0 for 16,250,000; 14,772,727; 11,054,544; and 8,930,685 shares (total = 51,007,956) — these reflect conversion/cancellation entries for derivative/preferred instruments, not open‑market sales.
• Net notable cash activity: a nearly $10.0M open‑market purchase (bullish cash purchase). The conversion entries are derivative accounting events tied to preferred-to-common conversions rather than routine buy/sell trades.

Key Details

• Date: 2026-08-06 (filing accession 0001231919-26-000838). Purchase price: $17.00; purchase value: $9,999,995.
• Shares from open‑market purchase: 588,235. Converted (acquired) shares via derivative conversion: 5,490,629. Conversion/cancellation (reported as dispositions at $0): 51,007,956.
• Shares owned after transaction: not specified in the provided excerpt — see the full Form 4 for post‑transaction beneficial ownership.
• Footnotes of note:
  • Several series of preferred stock (Series A‑1, A‑2, B, C) automatically converted into common stock on a 9.29:1 basis upon the issuer's IPO (per F1, F3–F5).
  • Frazier Life Sciences XI, L.P. is directly held; FHMLS XI, L.P. and FHMLS XI, L.L.C. are related general partners (per F2).
• Filing timeliness: no late‑filing flag indicated in the provided data.

Context

• The $10M open‑market purchase is clear cash-backed buying by a 10% institutional holder — purchases often draw more attention than routine sales because they show committed capital, though they do not prove intent or future performance.
• The many $0 dispositions are bookkeeping results of converting preferred/derivative securities into common shares (automatic IPO conversions), not sales to third parties. As a 10% institutional owner, this filing reflects fund/investor activity rather than a company executive's personal trading.